Skip to main content
OpenTrials

Clinical trial condition

Digestive System Diseases

Explore clinical trials studying Digestive System Diseases. Study availability and eligibility vary by location and protocol.

31,800 public trials 5,675 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Diseases trial results

Terminated

A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

NCT05328908

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +18 more
Locations
  • Local Institution - 0044 Springdale, Arkansas, United States
  • Local Institution - 0012 Los Angeles, California, United States
  • Local Institution - 0117 Norwich, Connecticut, United States
  • Local Institution - 0025 Miami, Florida, United States
View all 139 locations
View Trial Details
Terminated

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

NCT04601428

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • National Cheng Kung University Hospital (NCKUH) Tainan, North Dist., Taiwan
  • Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC) Taipei, Pei-Tou Dist., Taiwan
  • National Taiwan University Hospital (NTUH) Taipei, Zhongzheng Dist., Taiwan
  • KFSYSCC Taipei, Taiwan
View Trial Details
Terminated

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

NCT04949256

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • City of Hope ( Site 0102) Duarte, California, United States
  • MedStar Washington Hospital Center ( Site 0186) Washington D.C., District of Columbia, United States
  • James Graham Brown Cancer Center ( Site 0117) Louisville, Kentucky, United States
  • Norton Cancer Institute ( Site 0116) Louisville, Kentucky, United States
View all 198 locations
View Trial Details
Terminated

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

NCT05435014

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • Tungs' Taichung Metroharbor Hospital Taichung, Taiwan
  • National Cheng Kung University Hospital Tainan, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details

Related conditions